Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00946088 · ClinicalTrials.gov registry record · Phase 2
Progesterone for Maintenance Tocolysis: A Randomized Placebo Controlled Trial
A Phase 2 study, sponsored by Stanford University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT00946088: Clinical Trial Phase 2 study, sponsored by Stanford University.
NCT00946088 is a Phase 2 study that was terminated before completion, run by Stanford University. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00946088, a Phase 2 study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
Preterm delivery is the most common cause of infant morbidity and mortality in the United States. Some women have episodes of preterm labor during their pregnancy which can be temporarily stopped. These women, however, are at high risk for delivering before term. At this time, we do not have sufficient evidence to use any medication to help prevent these women from delivering early. Recently, preliminary studies have shown that progesterone may help prevent some women at high risk for preterm delivery from delivering early. Our study will investigate whether progesterone can help this specific group of women, women with arrested preterm labor, deliver healthy infants at term.
Interventions
- DRUG Progesterone
- DRUG Polyethylene glycol&hydrogenated vegetable oil.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-10 |
| Est. Completion | 2015-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00946088
The ClinicalTrials.gov registry entry for NCT00946088 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Progesterone is the first listed.
NCT00946088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00946088 about?
NCT00946088 is a clinical study titled "Progesterone for Maintenance Tocolysis: A Randomized Placebo Controlled Trial". Preterm delivery is the most common cause of infant morbidity and mortality in the United States. Some women have episodes of preterm labor during their pregnancy which can be temporarily stopped. These women, however, are at high risk for delivering before term. At this time, we do not have suffici...
What is the current status of trial NCT00946088?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2009-10. Estimated completion is 2015-03.
What interventions are being tested in trial NCT00946088?
The interventions under investigation include: Progesterone (DRUG), Polyethylene glycol&hydrogenated vegetable oil. (DRUG).
Who is sponsoring clinical trial NCT00946088?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.